-
281
-
282
The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors)
Published 2024-01-01Subjects: Get full text
Article -
283
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
Published 2025-02-01Subjects: “…Histone deacetylase inhibitors…”
Get full text
Article -
284
Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
Published 2020-12-01Subjects: Get full text
Article -
285
Virtual Screening, Toxicity Evaluation and Pharmacokinetics of Erythrina Alkaloids as Acetylcholinesterase Inhibitor Candidates from Natural Products
Published 2025-02-01Subjects: “…acetylcholinesterase inhibitors…”
Get full text
Article -
286
Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
Published 2020-06-01Subjects: “…proton pump inhibitors…”
Get full text
Article -
287
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Published 2025-01-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
288
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
289
The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature
Published 2025-02-01Subjects: “…SGLT2 inhibitors…”
Get full text
Article -
290
Effect of antithrombotic therapies on small bowel bleeding: an European multicenter retrospective study
Published 2025-01-01Subjects: “…platelet aggregation inhibitors…”
Get full text
Article -
291
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: Get full text
Article -
292
Activity trypsin-like proteinases and intestinal mucosa collagen degradation at gastro-intestinal diseases
Published 2010-04-01Subjects: Get full text
Article -
293
Synthesis and kinetic evaluation of analogs of (E)-4-amino-3-methylbut-2-en-1-yl diphosphate, a potent inhibitor of the IspH metalloenzyme
Published 2023-12-01Subjects: Get full text
Article -
294
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
Published 2025-01-01Subjects: Get full text
Article -
295
Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
Published 2025-02-01Subjects: Get full text
Article -
296
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Published 2025-01-01Subjects: Get full text
Article -
297
Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
Published 2015-12-01Subjects: Get full text
Article -
298
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
Published 2025-01-01Subjects: Get full text
Article -
299
-
300
The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
Published 2025-03-01Subjects: Get full text
Article